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Background and study aims: Colon capsule endoscopy (CCE) was developed for the 
 evaluation of colorectal pathology. In this study, our aim was to assess if a dual-camera analy-
sis using CCE allows better evaluation of the whole gastrointestinal (GI) tract compared to a 
single-camera analysis.
Patients and methods: We included 21 patients (12 males, mean age 56.20 years) submitted 
for a CCE examination. After standard colon preparation, the colon capsule endoscope (PillCam 
Colon™) was swallowed after reinitiation from its “sleep” mode. Four physicians performed 
the analysis: two reviewed both video streams at the same time (dual-camera analysis); one 
analyzed images from one side of the device (“camera 1”); and the other reviewed the opposite 
side (“camera 2”). We compared numbers of findings from different parts of the entire GI tract 
and level of agreement among reviewers.
Results: A complete evaluation of the GI tract was possible in all patients. Dual-camera 
analysis provided 16% and 5% more findings compared to camera 1 and camera 2 analysis, 
respectively. Overall agreement was 62.7% (kappa = 0.44, 95% CI: 0.373–0.510). Esophageal 
(kappa = 0.611) and colorectal (kappa = 0.595) findings had a good level of agreement, while 
small bowel (kappa = 0.405) showed moderate agreement.
Conclusion: The use of dual-camera analysis with CCE for the evaluation of the GI tract is 
feasible and detects more abnormalities when compared with single-camera analysis. 
Keywords: capsule endoscopy, colon, gastrointestinal tract, small bowel
Introduction
Capsule endoscopy (CE) has been established as an extremely useful diagnostic 
tool for the evaluation of obscure gastrointestinal bleeding (OGIB) and other small-
bowel conditions.1,2 Currently, CE is approved in adult and pediatric patients older 
than 10 years for evaluation of OGIB,3,4 celiac disease,5 polyposis syndromes,6,7 and 
small-bowel abnormalities detected in imaging studies.8–10
This technology has evolved over the last decade, and new and better devices are 
available, such as capsules with two lenses and cameras and those capable of capturing 
more frames per second.2,11 The PillCam ESO™ esophageal capsule (Given Imaging, 
Yoqneam, Israel), for example, has two cameras, each with the capability of taking 
images at seven frames per second.12,13 This device has been approved for screening 
and follow-up of esophageal varices and screening for Barrett’s esophagus.12,14,15 More 
recently, a colon capsule endoscope (PillCam Colon™; Given Imaging) has been 
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developed.16 The colon capsule is similar to the conventional 
capsule, but has two cameras that are able to record video 
images from both ends.17 The device measures 31 × 11 mm 
and acquires images at a rate of four frames per second. The 
preprogrammed “sleep” mode allows recording of images 
from the esophagus and stomach for 3 minutes, after which 
the capsule switches to sleep mode for 1 hour 45 minutes. 
During this period, the capsule is likely to transit most of 
the small bowel; thus, by the time the capsule “wakes up” 
from its sleep period, it will have reached approximately 
the terminal ileum. The preprogrammed sleep mode saves 
battery, thereby allowing an almost complete evaluation of 
the colon.
Several studies have pointed out the effectiveness 
of the PillCam Colon™ capsule endoscope compared 
to colonoscopy for the study of colon diseases.18–20 The 
high-priority objective of colon capsule endoscopy (CCE) 
is screening for colorectal cancer in at-risk populations.21 
CCE can be performed when there is a contraindication 
for colonoscopy, and it is suitable for patients who are 
unwilling to undergo colonoscopy or to complete a failed 
colonoscopy. It can also be used for follow-up of condi-
tions different to adenomas or polyps, such as ulcerative 
colitis (UC).22
Although CCE was developed for evaluation of the 
colon, this dual device can also be used to assess the entire 
GI tract if the patient takes the capsule after early activation 
and as soon as the capsule recovers from its sleep mode. In 
a previous study, Almeida et al23 performed a study in which 
the colon capsule was given after the device woke up from 
sleep mode to ten patients for small-bowel evaluation. In 
this study, the authors found that enteroscopy with a double-
camera device allowed the detection of more findings and 
increased diagnostic accuracy when compared to a single-
camera analysis.23
In our study, our aim was to determine if the use of CCE 
and a dual-camera analysis allows a better evaluation of the 
entire gastrointestinal (GI) tract when compared to a single-
camera analysis. In addition, we also analyzed the level 
of agreement between double-camera and single-camera 
analysis.
Patients and methods
Patients
This prospective, exploratory, and pilot study was conducted 
between September 2007 and October 2009 at the Hospital 
Virgen de la Macarena, Seville, Spain. Twenty-one (12 male, 
mean age 56.20 years, range 23–97 years) consecutive 
 Hispanic patients submitted for a PillCam Colon™ examina-
tion were included. These patients were submitted for CCE 
for: screening to rule out organic diseases (n = 10); follow-
up of inflammatory bowel disease ([IBD] eg, Crohn’s or UC 
history [n = 5]); chronic anemia (n = 3); chronic abdominal 
pain (n = 3); and chronic diarrhea (n = 1). Subjects were 
invited to participate, and those who agreed gave their written 
informed consent for the procedure and the protocol analysis. 
This protocol was approved by the internal ethics committee 
of the Hospital Virgen de la Macarena.
study protocol
small-bowel and colon preparation
All patients underwent a 48-hour standard colon prepara-
tion for the colon capsule procedure previously described 
by Herrerías-Gutiérrez et al.17 Forty-eight hours before the 
study, the patients were put on a low-fiber diet and were 
instructed to drink ten glasses of water during the day. 
Four pills of Pursennid (12 mg sennosides A and B) were 
prescribed to be taken at night. The day before the test, a 
clear liquid diet was prescribed (water, apple juice, tea or 
black coffee, transparent carbonated fluids, ice cream or 
jelly without red or violet color, chewing gum), then the 
patients received 1 L polyethylene glycol solution between 
7 pm and 9 pm and another liter of this solution between 
7 am and 8.30 am on the day of the examination. Before (at 
9.15 am) and 15 minutes after swallowing the capsule, the 
patients received 20 mg of domperidone. Two hours later, 
after confirming the capsule’s exit from the stomach with the 
real-time viewing system (Rapid Access Real Time; Given 
Imaging); the patient received 30 mL sodium phosphate solu-
tion (Fleet Phospho Soda; Casen-Fleet Laboratories, Utebo, 
Spain) as a booster dose. A second booster dose of 30 mL 
sodium phosphate solution was administered 3 hours after 
the first one if the capsule was not excreted in this period. If 
necessary, a bisacodyl suppository (Dulcolax; Boehringer 
Ingelheim, Ingelheim am Rhein, Germany) was used. Small-
bowel and colon cleanliness were assessed using a grading 
scale, previously reported by Herrerías-Gutiérrez et al, with 
four grades: very good, good, fair, and poor.17
PillCam Colon™ CCE device
The PillCam Colon™ capsule used in this study is the con-
ventional capsule (31 × 11 mm) with two cameras that enable 
the device to acquire images from opposite directions with a 
wide coverage area, acquiring pictures at a rate of four frames 
per second. This device has a 10-hour battery life. After 
3 minutes of running, the capsule turns off for a period of 1 
Clinical and Experimental Gastroenterology 2013:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
187
single- and dual-camera CCE analysis of the gastrointestinal tract
hour 45 minutes and then “wakes up” and restarts the trans-
mission of images. For this protocol, we activated the PillCam 
prior to the procedure; the patient swallowed the capsule after 
the sleep period in order that images could be obtained from 
the whole GI tract.
Data interpretation and analysis
Four different physicians with experience in PillCam exami-
nations interpreted the recorded data. After ingestion of the 
capsule, the images were read at a maximum speed of eight 
frames per second. Since we wanted to analyze the entire GI 
tract, all pathological findings, from the mouth to the rectum, 
were considered. When CCE is performed, the Rapid Viewer 
Software™ (v 6; Given Imaging) allows simultaneous analy-
sis of both cameras (dual-camera analysis) or single-camera 
analysis by deactivation of one of the two streams. In order 
to achieve a complete and more accurate evaluation and 
analysis, two physicians (PHD and JMHG) observed both 
video streams at the same time (dual-camera analysis). One 
physician (VAJG) saw only the images taken from one side 
of the device (conventionally named “camera 1”), and the 
other (JMRT) saw only the images from the opposite side 
(“camera 2”). The physicians were blinded to each other’s 
results to avoid bias.
statistical analysis
The physicians counted the total number of findings and 
described these for each case. The findings were catego-
rized according to the area of the GI tract in which they 
were located: esophagus, stomach, small bowel (duodenum, 
jejunum, ileum); or colon, rectum, and other (eg, mouth). 
We compared the number of individual findings detected 
by camera 1 versus by dual-camera analysis (ie, VAJG vs 
PHD and JMHG) and then by camera 2 (JMRT vs PHD 
and JMHG) to determine the level of agreement between 
the involved physicians and to exclude interobserver dis-
agreement bias. We also compared the findings between 
camera 1 and camera 2 to determine the levels of agreement 
and reproducibility. An overall agreement level for all three 
analyses (dual-camera analysis, camera 1, and camera 2) was 
also calculated. Strength of agreement was classified as fol-
lows: ,0.20 = poor; 0.21–0.40 = fair; 0.41–0.60 = moderate; 
0.61–0.80 = good; 0.81–1.00 = very good.
A descriptive analysis was performed using absolute val-
ues and percentages, with mean and range when appropriate. 
To evaluate the strength of agreement between dual-camera 
and single-camera observers, chance-adjusted kappa coef-
ficients with 95% confidence intervals (CIs) were calculated 
for overall analysis as well as for individual GI tract areas of 
evaluation (esophagus, stomach, small bowel, and colon and 
rectum), and for specific diagnoses (eg, hiatal hernia, erosive 
esophagitis, diverticular disease, vascular lesions, etc).
Results
A total evaluation of the entire GI tract was possible in all 
patients. The quality of small-bowel and colon prepara-
tion was very good in all cases. The mean total endoscope 
transit time was 325 minutes (range 150–691 minutes). 
Mean esophageal transit time was 7.78 seconds (range 
1–42 seconds), mean gastric transit time was 65.28 minutes 
(range 11–343 minutes), mean small bowel transit time was 
131.33 minutes (range 48–254 minutes), and mean colonic 
transit time was 123.80 minutes (range 14–406 minutes). 
No difficulties in swallowing the capsule nor adverse or side 
effects related to the procedure were observed.
Overall, dual-camera analysis detected a total  number of 
findings of 148, single-camera analysis with camera 1 detected 
128 findings, and single-camera analysis with  camera 2 
detected 135 findings. Thus, dual-camera analysis provided 
16% and 5% more findings compared to camera 1 and 
camera 2, respectively. The types of findings and their 
 locations are summarized in Table 1.
Agreement between dual-camera analysis and camera 1 
was 66% (kappa = 0.322, 95% CI: 0.211–0.434), correspond-
ing to a fair agreement. The agreement between dual-camera 
analysis and camera 2 was 76% (kappa = 0.513, 95% CI: 
0.414–0.613), corresponding to a moderate agreement. 
The agreement between camera 1 and camera 2 was 64% 
(kappa = 0.278, 95% CI: 0.16–0.394), corresponding to a 
fair agreement. Overall agreement level for all three analyses 
(dual-camera analysis, camera 1, and camera 2), concerning 
all findings, was 62.7% (kappa = 0.442, 95% CI: 0.373–
0.510). Overall agreement levels (three-level agreement) 
according to the site of the GI tract where the findings were 
detected are shown in Table 2. Esophageal (kappa = 0.611), 
and colorectal (kappa = 0.595) findings had the best overall 
level of agreement, while small bowel (kappa = 0.405) was 
the site with the least agreement (Table 2).
A total of 31 small-bowel angiodysplasias were detected 
(eleven by dual-camera analysis, nine by camera 1, and 
eleven by camera 2). Forty-seven colorectal polyps were 
detected (17 by dual-camera analysis, 15 by camera 1, and 
14 by camera 2). Most of the polyps were less than 6 mm. 
Table 3 shows the overall levels of agreement for specific 
diseases. Perfect agreement was observed in UC and 
Crohn’s disease (kappa = 1), where all observers reported 
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Table 1 Whole gastrointestinal tract findings detected by each camera separately and by both cameras simultaneously
Findings Dual analysis (both cameras) 
(n)
Single analysis (camera 1) 
(n)
Single analysis (camera 2) 
(n)
Total number of findings 148 128 135
Esophageal
 Esophageal diverticuli 
 schatzki ring 
 hiatal hernia 
 Erosive esophagitis 
 Barrett esophagus 
 Venous ectasia 
 Esophageal varices 
 Glycogenic acanthosis
1 
1 
7 
5 
2 
1 
1 
4
0 
0 
6 
5 
1 
0 
2 
3
0 
1 
7 
6 
2 
0 
1 
3
stomach
 Congestive gastropathy 
 Gastric polyps 
 Gastric angiodysplasia 
 Bile reflux 
 Gastric hyperplasia
9 
4 
1 
0 
0
9 
4 
3 
2 
3
10 
3 
2 
2 
1
small bowel
 Brunner’s gland hyperplasia 
 Duodenitis 
 Duodenum polyps 
 lymphangiectasia 
 Celiac disease (atrophy) 
 Duodenal varices 
 Duodenal angiodysplasia 
 Duodenum diverticuli 
 Jejunal angiodysplasia 
 Jejunal polyps 
 Jejunal venous ectasia 
 isolated jejunal ulcers 
 Jejunal xanthoma 
 ileal angiodysplasia 
 nodular lymphoid hyperplasia 
 ileal Crohn’s disease 
 nsaiD enteropathy 
 ileal cyst 
 ileal diverticuli 
 ileal polyp 
 ileal venous ectasia
1 
3 
2 
16 
5 
1 
1 
0 
2 
2 
0 
4 
0 
1 
5 
2 
1 
2 
2 
0 
0
1 
4 
2 
15 
1 
0 
2 
1 
4 
2 
4 
3 
1 
0 
2 
2 
0 
1 
4 
2 
4
1 
3 
1 
13 
4 
0 
1 
1 
3 
1 
1 
3 
0 
0 
6 
2 
2 
0 
2 
1 
0
Colon and rectum
 Diverticular disease 
 Colon ulcers 
 Ulcerative colitis 
 Cecum angiodysplasia 
 sigmoid angiodysplasia 
 Transverse angiodysplasia 
 rectal polyps 
 sigmoid polyps 
 right colon polyps 
 Transverse colon polyps 
 sigmoid malignancies 
 rectal ulcer 
 Proctitis 
 hemorrhoids
17 
4 
2 
4 
3 
0 
7 
5 
2 
1 
2 
1 
0 
13
18 
2 
2 
2 
1 
1 
4 
8 
3 
2 
1 
1 
1 
5
16 
2 
2 
5 
1 
1 
5 
6 
2 
2 
1 
1 
0 
8
Other
 Geographic tongue 
 soft palate erythema
1 
0
0 
2
0 
0
Abbreviation: NSAID, nonsteroidal anti-inflammatory drug.
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Table 2 Overall agreement (three levels) according to different sections of the gastrointestinal tract
Site of findings Dual analysis  
(both cameras) 
(n)
Single analysis  
(camera 1) 
(n)
Single analysis  
(camera 2) 
(n)
Level of  
agreement
Kappa 
(95% CI)
Esophagus 22 17 20 0.741 0.611 
(0.43–0.792)
stomach 14 21 18 0.673 0.510 
(0.319–0.701)
small bowel 50 55 45 0.605 0.405 
(0.291–0.520)
Colon and rectum 61 51 52 0.730 0.595 
(0.48–0.709)
Table 3 Overall agreement (three levels) according to specific 
diagnoses among observers
Disease Level of  
agreement
Kappa 95% CI
Crohn’s disease 1.0 1.0 –
Ulcerative colitis 
hiatal hernia 
Erosive esophagitis 
Diverticular disease of the colon
lymphangiectasia 
hemorrhoids 
Gastropathy 
Celiac disease 
Colorectal polyps 
nodular lymphoid  
hyperplasia 
nsaiD enteropathy
1.0 
0.90 
0.875 
0.875 
0.864 
0.786 
0.714 
0.667 
0.660 
 
0.615 
0.600
1.0 
0.851 
0.812 
0.812 
0.795 
0.643 
0.571 
0.500 
0.491 
 
0.393 
0.375
– 
0.54–1.156 
0.465–1.159 
0.612–1.012 
0.585–1.004 
0.369–0.916 
0.309–0.832 
0.175–0.825 
0.290–0.691 
 
0.001–0.785 
-2.64–1.014
small-bowel  
angiodysplasias
0.58 0.372 0.126–0.618
Abbreviation: NSAID, nonsteroidal anti-inflammatory drug.
similar findings in all cases (Figure 1). A good agreement 
was observed for hiatal hernia (kappa = 0.851), erosive 
esophagitis (kappa = 0.812), and diverticular disease of the 
colon (kappa = 0.812 ). The lowest levels of agreement were 
observed in small-bowel diseases such as angiodysplasias 
(kappa = 0.375), and nonsteroidal anti-inflammatory drug 
(NSAID) enteropathy (kappa = 0.372) (Figure 1).
Discussion
According to the European Society of Gastrointestinal 
Endoscopy (ESGE), CCE is considered a feasible and safe 
technique that seems to be accurate when used in average-risk 
individuals, may be cost-effective in screening for colorectal 
cancer compared with colonoscopy, and represents a useful 
tool for visualization of the colonic mucosa in patients with 
incomplete colonoscopy.21
Information regarding the use of small-bowel cap-
sule endoscopy and CCE beyond its indications is scarce. 
Figure 1 small-bowel images obtained with capsule endoscopy of the colon.
Notes: images of a patient with ileal Crohn’s disease obtained with camera 1 (A) 
and camera 2 (B). in this case, the two cameras showed the presence of the disease. 
Images of a patient with nonsteroidal anti-inflammatory drug enteropathy obtained 
with camera 1 (C) and camera 2 (D). in this case, only camera 2 revealed the 
presence of a circumferential ulceration.
Kobayashi et al,24 in a study of 55 patients with OGIB, evalu-
ated the diagnostic yield of small-bowel capsule endoscopy 
for gastric diseases, and found that this technique has, for 
diffuse lesions, sensitivity and specificity of 70% and 82%, 
respectively. However, for localized lesions, sensitivity and 
specificity were 28% and 63%, respectively. In another study, 
Rana et al25 found that up to 10% of 87 subjects evaluated with 
the small-bowel capsule had colonic abnormalities (including 
angiodysplasias, neoplasias, polyps, and Crohn’s disease), 
suggesting that, along with appropriate preparation, the colon 
should also be carefully evaluated in patients undergoing small-
bowel capsule endoscopy. Almeida et al,23 with the opposite 
approach to Rana et al’s study, found that double-camera ent-
eroscopy using CCE increases the rate of detection for small-
bowel abnormalities. Although Almeida et al23 first described 
the use of CCE to perform a double-camera enteroscopy, this 
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study included only ten patients and the aim was solely to 
evaluate the small bowel.
Following a protocol similar to that used by Almeida 
et al,23 we evaluated the whole GI tract; to our knowledge, this 
was the first study to do so. The entire GI tract evaluation was 
feasible because the double-camera capsule was swallowed 
after it restarted from the sleep mode. Thus, CCE may be used 
as a noninvasive, all-in-one technique to visualize the entire 
GI tract from the esophagus to the colon and rectum.
A major benefit of the double camera is that it significantly 
increases the area able to be evaluated, but also, as shown in 
our study, both cameras capture different sets of images that 
are not mutually reproducible (kappa between camera 1 and 
camera 2 was 0.278). Thus, a dual and simultaneous analysis 
of both cameras allows a more precise assessment of the GI 
tract. Although the overall agreement between observers was 
between fair and moderate for the entire GI evaluation, the 
dual-camera analysis detected between 5% and 16% more 
abnormalities compared to single-camera analysis. Previous 
studies have estimated that the miss rate for single-capsule 
endoscopy ranges between 11% and 19%.2,26 Problems such 
as the potential to miss a single-mass lesion and poor visual-
ization of some segments of the small bowel are less likely 
to occur if a CCE is used.
Interestingly, we found that, for some areas of the GI 
tract and for some diseases, the overall concordance was 
moderate to good. For example, kappa for overall esophageal 
findings, erosive esophagitis, and hiatal hernia were 0.611, 
0.51, and 0.812, respectively. Similar results have been 
previously reported with kappa values ranging from 0.42 to 
0.67 for esophagitis.12,27 In contrast, the use of esophageal 
capsule endoscopy demonstrates moderate sensitivity and 
specificity for the diagnosis of Barrett’s esophagus. In our 
study, the number of patients with Barrett’s esophagus was 
small (n = 2); thus, we cannot assess the agreement for this 
condition.
Small-bowel capsule endoscopy provides a high diagnostic 
yield for small-bowel mucosal lesions, and its use is recom-
mended in specific scenarios of IBD, such as in the pediatric 
population, where it may help lead to a definitive diagnosis 
and sometimes can result in reclassification of UC/indetermi-
nate colitis to Crohn’s disease.28–30 To date, the role of CCE in 
IBD has been evaluated in only one case series.22 Specifically, 
CCE has been compared with colonoscopy with the aim of 
evaluating its accuracy in monitoring colonic inflammation 
in patients with suspected or known UC. In this preliminary 
experience, CCE yielded encouraging results for detecting 
active ulcerative colitis (ie, sensitivity 77%,  specificity 78%) 
and good agreement with colonoscopy. Although we had a 
small sample size, we found that, for detecting IBD, CCE is 
a good method with a high level of agreement.
Regarding other colorectal findings, a good agreement 
level was found for diverticular disease of the colon. To our 
knowledge, ours is the first study to report on this disease. 
It is essential to remark that, in all cases, diverticular dis-
ease was considered non-complicated. Further studies are 
required to analyze diagnostic accuracy and clinical use 
of CCE for diverticular disease of the colon. We found 47 
 polyps, most of which were small. As reported by others, 
most colonic polyps discovered at screening are diminutive, 
with negligible risk of harboring advanced features (high-
grade dysplasia, villous component, or malignancy).20,31 
Moreover, 40% of diminutive colonic polyps are hyperplastic 
rather than  adenomatous.32 Diminutive lesions identified 
by a noninvasive test may also be missed by colonoscopy, 
because of the imperfect sensitivity of the latter for diminu-
tive lesions.33
It is also important to remark that, in up to 62% (13/21) 
of our subjects, internal hemorrhoids were detected by CCE. 
This finding makes obvious that a bowel preparation using 
booster doses of 30 mL sodium phosphate solution can 
guarantee that the capsule reaches the rectum, allowing a 
complete GI evaluation.
Comparing single-camera analysis and dual-camera 
analysis, the lower level of agreement was observed in small-
bowel diseases such as angiodysplasias (kappa = 0.375), and 
NSAID enteropathy (kappa = 0.372 ). This finding could be 
explained because single-camera analysis has limited vision 
and each camera may capture different, non-reproducible 
findings. Thus, according to our results, as in the Almeida 
study,23 a double-camera enteroscopy using CCE is a better 
option for complete evaluation of small-bowel diseases.
There are some limitations in our study that should be 
acknowledged. First of all, the study had a small sample size 
and the CCE was used in different diseases. Also, we did not 
evaluate the upper part of the GI tract, the small bowel, or 
the colon with other invasive techniques (such as endoscopy, 
enteroscopy, and colonoscopy), but we must say that this was 
beyond our aim. Further studies are required to compare 
findings detected by CCE in the whole GI tract versus those 
detected with standard techniques. The statistical agreement 
analysis was calculated for overall findings and for some 
lesions because there were not enough subjects to do a per-
patient analysis. Also, because each patient had more than 
one abnormality detected by CCE, an analysis per patient 
was extremely difficult to perform.
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Although we have shown, using CCE, that more find-
ings could be detected in the colon and other parts of the 
GI tract, this technique does not exclude false negative 
results at all. For example, a CCE examination may be 
incomplete, mainly because of a slow GI transit that may 
mean that the capsule stays longer periods in some seg-
ments of the GI tract. Therefore, some segments may not 
be visualized by CCE. In addition, although we describe 
that an entire GI tract evaluation was possible in all cases, 
we must acknowledge that some parts of the stomach, 
specifically the fundus, are not able to be assessed using 
capsule endoscopy.
Conclusion
The use of a dual-camera analysis using CCE for the evalua-
tion of the GI tract is feasible and detects more abnormalities 
when compared with a single-camera analysis. However, 
further studies are required that include larger sample sizes, 
specific populations (eg, obscure bleeding), and a cost-
effectiveness analysis.
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